163 related articles for article (PubMed ID: 30860874)
21. Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress.
Yang G; Lei Y; Inoue A; Piao L; Hu L; Jiang H; Sasaki T; Wu H; Xu W; Yu C; Zhao G; Ogasawara S; Okumura K; Kuzuya M; Cheng XW
Atherosclerosis; 2017 Sep; 264():1-10. PubMed ID: 28734203
[TBL] [Abstract][Full Text] [Related]
22. Liraglutide Activates AMPK Signaling and Partially Restores Normal Circadian Rhythm and Insulin Secretion in Pancreatic Islets in Diabetic Mice.
Wang K; Sun Y; Lin P; Song J; Zhao R; Li W; Hou X; Wang C; Wang L; Zhu P; Chen L
Biol Pharm Bull; 2015; 38(8):1142-9. PubMed ID: 26040899
[TBL] [Abstract][Full Text] [Related]
23. Reduced expression of ERp46 under diabetic conditions in β-cells and the effect of liraglutide.
Lampropoulou E; Lymperopoulou A; Charonis A
Metabolism; 2016 Jan; 65(1):7-15. PubMed ID: 26683792
[TBL] [Abstract][Full Text] [Related]
24. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
25. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
[TBL] [Abstract][Full Text] [Related]
26. The glucagon-like peptide-1 analogue liraglutide promotes autophagy through the modulation of 5'-AMP-activated protein kinase in INS-1 β-cells under high glucose conditions.
Miao X; Gu Z; Liu Y; Jin M; Lu Y; Gong Y; Li L; Li C
Peptides; 2018 Feb; 100():127-139. PubMed ID: 28712893
[TBL] [Abstract][Full Text] [Related]
27. Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals.
Christodoulou E; Kadoglou NPE; Stasinopoulou M; Konstandi OA; Kenoutis C; Kakazanis ZI; Rizakou A; Kostomitsopoulos N; Valsami G
Atherosclerosis; 2018 Jan; 268():207-214. PubMed ID: 29128090
[TBL] [Abstract][Full Text] [Related]
28. Glucagon-like peptide-1 increased the vascular relaxation response via AMPK/Akt signaling in diabetic mice aortas.
Taguchi K; Bessho N; Kaneko N; Okudaira K; Matsumoto T; Kobayashi T
Eur J Pharmacol; 2019 Dec; 865():172776. PubMed ID: 31697935
[TBL] [Abstract][Full Text] [Related]
29. 5'-AMP-activated protein kinase-activating transcription factor 1 cascade modulates human monocyte-derived macrophages to atheroprotective functions in response to heme or metformin.
Wan X; Huo Y; Johns M; Piper E; Mason JC; Carling D; Haskard DO; Boyle JJ
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2470-80. PubMed ID: 24051143
[TBL] [Abstract][Full Text] [Related]
30. Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.
Helmstädter J; Frenis K; Filippou K; Grill A; Dib M; Kalinovic S; Pawelke F; Kus K; Kröller-Schön S; Oelze M; Chlopicki S; Schuppan D; Wenzel P; Ruf W; Drucker DJ; Münzel T; Daiber A; Steven S
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):145-158. PubMed ID: 31747801
[TBL] [Abstract][Full Text] [Related]
31. GLP-1 receptor agonist impairs keratinocytes inflammatory signals by activating AMPK.
Yang J; Wang Z; Zhang X
Exp Mol Pathol; 2019 Apr; 107():124-128. PubMed ID: 30776356
[TBL] [Abstract][Full Text] [Related]
32. Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice.
Tsai TH; Lee CH; Cheng CI; Fang YN; Chung SY; Chen SM; Lin CJ; Wu CJ; Hang CL; Chen WY
Cells; 2019 Jun; 8(6):. PubMed ID: 31207939
[TBL] [Abstract][Full Text] [Related]
33. The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism.
Andreozzi F; Raciti GA; Nigro C; Mannino GC; Procopio T; Davalli AM; Beguinot F; Sesti G; Miele C; Folli F
J Transl Med; 2016 Jul; 14(1):229. PubMed ID: 27473212
[TBL] [Abstract][Full Text] [Related]
34. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
[TBL] [Abstract][Full Text] [Related]
35. Comparative Analysis of the Anti-Inflammatory Effects of Liraglutide and Dulaglutide.
Hou Y; Fan Y; Cheng Y; Peng X; Shan C; Yang Y
Int Heart J; 2024 May; 65(3):548-556. PubMed ID: 38749748
[TBL] [Abstract][Full Text] [Related]
36. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
37. Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
Doddapattar P; Dhanesha N; Chorawala MR; Tinsman C; Jain M; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):520-528. PubMed ID: 29348121
[TBL] [Abstract][Full Text] [Related]
38. Longxuetongluo capsule inhibits atherosclerosis progression in high-fat diet-induced ApoE
Zheng J; Liu B; Lun Q; Gu X; Pan B; Zhao Y; Xiao W; Li J; Tu P
Atherosclerosis; 2016 Dec; 255():156-163. PubMed ID: 27591127
[TBL] [Abstract][Full Text] [Related]
39. Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment.
Wang L; Li P; Tang Z; Yan X; Feng B
Sci Rep; 2016 Sep; 6():33251. PubMed ID: 27633081
[TBL] [Abstract][Full Text] [Related]
40. GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1β-induced metabolic disturbance and mitochondrial dysfunction.
Zhang L; Tian J; Diao S; Zhang G; Xiao M; Chang D
Chem Biol Interact; 2020 Dec; 332():109252. PubMed ID: 32898504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
